Nu-Med Plus (NUMD) Liabilities and Shareholders Equity (2011 - 2025)
Nu-Med Plus recorded quarterly Liabilities and Shareholders Equity of $7911.0 in Q4 2025, up 56.72% quarter-over-quarter from $5048.0 in Q3 2025, and down 15.6% year-over-year from $9373.0 in Q4 2024.
Nu-Med Plus' Liabilities and Shareholders Equity history runs 15 years deep, the most recent figure standing at $7911.0 for Q4 2025.
- In Q4 2025, Liabilities and Shareholders Equity fell 15.6% year-over-year to $7911.0; the TTM figure through Dec 2025 stood at $26295.0 (down 27.5% YoY), while the FY2025 annual figure was $7911.0, down 15.6% from the prior year.
- Liabilities and Shareholders Equity came in at $7911.0 for Q4 2025 at Nu-Med Plus, up from $5048.0 in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $285013.0 in Q1 2021 to a low of $3168.0 in Q3 2022.
- A 5-year average of $36600.4 and a median of $10207.0 in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity plunged 97.22% in 2022 and soared 645.26% in 2023, its largest moves.
- Nu-Med Plus' Liabilities and Shareholders Equity stood at $22163.0 in 2021, then surged by 258.91% to $79545.0 in 2022, then slumped by 83.08% to $13456.0 in 2023, then slumped by 30.34% to $9373.0 in 2024, then slipped by 15.6% to $7911.0 in 2025.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $7911.0, $5048.0, and $8163.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Nu-Med Plus | - | - | - | 7,911.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7,911.00 |
| Sep 30, 2025 | 5,048.00 |
| Jun 30, 2025 | 8,163.00 |
| Mar 31, 2025 | 5,173.00 |
| Dec 31, 2024 | 9,373.00 |
| Sep 30, 2024 | 6,841.00 |
| Jun 30, 2024 | 11,041.00 |
| Mar 31, 2024 | 9,016.00 |
| Dec 31, 2023 | 13,456.00 |
| Sep 30, 2023 | 13,748.00 |
| Jun 30, 2023 | 36,547.00 |
| Mar 31, 2023 | 59,069.00 |
| Dec 31, 2022 | 79,545.00 |
| Sep 30, 2022 | 3,168.00 |
| Jun 30, 2022 | 8,440.00 |
| Mar 31, 2022 | 7,926.00 |
| Dec 31, 2021 | 22,163.00 |
| Sep 30, 2021 | 51,236.00 |
| Jun 30, 2021 | 89,130.00 |
| Mar 31, 2021 | 285,013.00 |
| Dec 31, 2020 | 557,135.00 |
| Sep 30, 2020 | 649,561.00 |
| Jun 30, 2020 | 852,238.00 |
| Mar 31, 2020 | 47,219.00 |
| Dec 31, 2019 | 45,779.00 |
| Sep 30, 2019 | 83,667.00 |
| Jun 30, 2019 | 52,785.00 |
| Mar 31, 2019 | 154,501.00 |
| Dec 31, 2018 | 423,016.00 |
| Sep 30, 2018 | 552,451.00 |
| Jun 30, 2018 | 336,712.00 |
| Mar 31, 2018 | 325,011.00 |
| Dec 31, 2017 | 406,719.00 |
| Sep 30, 2017 | 459,408.00 |
| Jun 30, 2017 | 317,219.00 |
| Mar 31, 2017 | 349,748.00 |
| Dec 31, 2016 | 35,533.00 |
| Sep 30, 2016 | 252,882.00 |
| Jun 30, 2016 | 945,162.00 |
| Mar 31, 2016 | 127,179.00 |
| Dec 31, 2015 | 75,945.00 |
| Sep 30, 2015 | 62,721.00 |
| Jun 30, 2015 | 90,821.00 |
| Mar 31, 2015 | 100,630.00 |
| Dec 31, 2014 | 213,062.00 |
| Sep 30, 2014 | 213,062.00 |
| Jun 30, 2014 | 543,529.00 |
| Mar 31, 2014 | 501,517.00 |
| Dec 31, 2013 | 96,022.00 |
| Sep 30, 2013 | 66,631.00 |
| Jun 30, 2013 | 69,795.00 |
| Mar 31, 2013 | 70,146.00 |
| Dec 31, 2012 | 110,403.00 |
| Dec 31, 2011 | 1,406.00 |